Corinne Fuller has been named the new co-director of the Bioproducts Institute, a research collaboration between Washington State University and PNNL, as of July 2023.
PNNL has named Biomedical Scientist Tom Metz, an expert on metabolomics and multi-omics within the Biological Sciences Division, a 2023 Laboratory Fellow.
PNNL chemist Christopher Anderton recently named president-elect of the Imaging Mass Spectrometry Society (IMSS). In this new position, he will help lead the merge of IMSS with a European-based society, currently underway.
Bobbie-Jo Webb-Robertson is a leader with a PhD in decision sciences & engineering systems from Rensselaer Polytechnic Institute and experience in managing complex scientific programs and line organizations. She assumed the role 3/13/23.
Kathleen Doty recently shared legal insight on the challenge of space debris in her presentation “Regulating Space Junk” as part of the University of Georgia School of Law’s Spring 2023 Space Law Speaker Series.
PNNL Biomedical Scientist Geremy Clair has taken on new roles as an editor for two journals; Frontiers In Cellular And Infection Microbiology and Frontiers In Molecular Biosciences.
PNNL computational neuroscientist Rogene Eichler West honored with the International Society for Neuroregulation & Research Joseph and Ann Marie Horvat Distinguished Service Award.
Kate Doty was invited to lend her expertise as guest editor for the International Journal of Nuclear Security on a special issue on women in nuclear security.
Nonproliferation Policy and Law Analyst, Chanel Chauvet, served as the legal expert in the International Atomic Energy Agency's effort to update Uzbekistan's Integrated Nuclear Security Support Plan.
Read interviews with the new Laboratory fellows to learn about their contributions to their field, what drives them, and how their research is making the nation safer, greener, and more resilient.
John VerWey, East Asia national security advisor, delivered remarks on competition in global supply chains at a U.S.-China Economic Security Review Commission hearing in June 2022.